Avid Radiopharmaceuticals News

The Washington Post examines several ambitious new studies designed to accurately identify the early onset of Alzheimer's and use biomarkers to track the effectiveness of new therapies to prevent the Read more...

A study has found that researchers can detect Alzheimer's disease with a brain scan using radioactive dye called AV-45 or florbetapir, which was developed by Philadelphia-based Avid Read more...

While Alzheimer's has long represented an enormous potential market for drug developers, the field has been plagued for decades by some vexing scientific challenges. There often seems to be more Read more...